Not Accepting Cases

Accutane Lawsuits

Accutane users and their families filed more than 7,000 lawsuits against Hoffmann-LaRoche. A judge dismissed the majority of Accutane lawsuits in 2014. Jury verdicts against the manufacturer were overturned. In 2017, an appellate court reinstated more than 2,000 Accutane lawsuits. The New Jersey Supreme Court in 2018 was considering whether the lawsuits should move forward.

Accutane pills
Accutane Lawsuit Facts
  1. Injuries Birth defects, inflammatory bowel disease, depression and suicide
  2. Manufacturer Hoffman-LaRoche (Roche)
  3. Money Awarded $53 million in jury verdicts (overturned)

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Related Pages

* UPDATE: In 2018, a state Supreme Court was considering whether to allow 2,000 Accutane lawsuits to move forward. Drugwatch’s legal partners are not currently accepting Accutane cases.

People who took Accutane (isotretinoin) suffered severe side effects. These side effects included depression, suicide, ulcerative colitis and Crohn’s Disease.

Thousands of these patients and their loved ones sued Hoffman-LaRoche. They claimed the drugmaker did not warn them about the dangers of Accutane.

Judges dismissed the majority of Accutane lawsuits. Jury verdicts in favor of Accutane users were overturned.

But, in 2017, an appellate court reinstated more than 2,000 lawsuits filed in state court in New Jersey. The state Supreme Court in 2018 was considering whether these cases should proceed.

There have been no known large-scale settlements for patients injured by Accutane. Drugwatch’s legal partners are not taking Accutane cases now. But that could change in the future.

Status of Accutane Lawsuits

Accutane lawsuits were previously consolidated in Florida federal court. These cases wrapped up years ago in favor of Hoffman-LaRoche. This effectively put an end to federal Accutane lawsuits against the manufacturer.

More than 7,000 patients and family members filed Accutane lawsuits. Judges consolidated many of the federal cases into a multidistrict litigation in the Middle District of Florida.

Multidistrict litigation (MDL) is a way for federal courts to organize large numbers of similar lawsuits.

Roche tower
Hoffmann-La Roche, who manufacturers Accutane, has headquarters in Basel, Switzerland.

U.S. District Judge James Moody ultimately dismissed all the federal Accutane cases. Moody ruled that the warning label on Accutane was adequate.

A New Jersey state court organized thousands of cases filed in the state. The court grouped the cases under a different type of litigation known as multicounty litigation (MCL).

Juries ordered Hoffman-LaRoche to pay millions to patients. But, judges overturned those verdicts.

The New Jersey MCL judge dismissed more than 2,000 Accutane lawsuits. An appellate court reinstated those cases in 2017.

Hoffman-LaRoche appealed the reinstatements. The state Supreme Court agreed to consider the drug company’s appeals.

Injuries Mentioned in Accutane Lawsuits

Did You Know?
Inflammatory bowel disease (IBD) and suicide were two injuries mentioned in Accutane lawsuits.

The majority of Accutane lawsuits claimed the drug caused inflammatory bowel disease (IBD).

IBD is a condition that involves chronic inflammation of the gastrointestinal tract. IBD usually manifests in one of two diseases: ulcerative colitis or Crohn’s disease. IBD is a permanent condition.

Some people who sued Hoffman-LaRoche blamed Accutane for psychosis, depression and suicide. Others alleged the drug caused birth defects.

Accusations Against Accutane Manufacturer Hoffman-LaRoche

Accutane lawsuits said the drug is “defective.” The lawsuits also claimed the drug is “dangerous to human health, unfit and unsuitable to be marketed and sold in commerce.”

They said Accutane “lacked proper warnings as to the dangers associated with its use.” Lawsuits claimed Hoffmann-LaRoche had knowledge of a link between gastrointestinal symptoms and Accutane.

Before the FDA approved Accutane in 1982, it raised concerns about these issues. Despite this, Hoffmann-LaRoche did not include any warnings about the risk of IBD.

Accutane Settlements

Hoffmann-LaRoche reportedly settled some individual cases before they went to trial. But, there are no publicized reports of any large-scale settlements.

plaintiffs allege Accutane causes psychosis, suicide & depression

Hoffmann-LaRoche took Accutane off the market in 2009. It successfully fended off thousands of lawsuits.

The lawsuits alleged the company had endangered patients by marketing a harmful product.

Hoffmann-LaRoche argued people who filed lawsuits could not prove Accutane injured them.

The manufacturer claimed there were no scientific studies linking Accutane to IBD or suicide.

The manufacturer maintained they had given ample warning to patients about the potential side effects of Accutane.

Accutane Verdicts

Juries ordered Hoffmann-LaRoche to pay more than $53 million to Accutane patients. This total comes from several large judgments.

But, the company appealed the verdicts. Judges ruled in favor of Hoffmann-LaRoche in the majority of the cases.

  • Julia Bishop
    In 2002, Julia Bishop filed a lawsuit against Hoffmann-LaRoche. Her 15-year-old son Charles Bishop crashed a Cessna into the 28th floor of the Bank of America Building in Tampa, Florida. Bishop claimed Accutane caused her son to commit suicide. She demanded $70 million from Hoffmann-LaRoche, The Tampa Tribune reported. Five years later, Bishop withdrew her lawsuit. Her attorneys said she was emotionally and physically unable to continue due to personal attacks by the drugmaker.
  • Carla Gray
    Carla Gray of Ada, Oklahoma, took her Accutane depression case to trial in 2002. She asked for $3 million because the drug company failed to warn about depression. A jury denied her claim.
  • Kathleen Rossitto and Riley Wilkinson
    Kathleen Rossitto and Riley Wilkinson won their lawsuits in June 2012. Rossitto and Wilkinson claimed Accutane caused them to develop inflammatory bowel disease. A New Jersey court ordered Hoffmann-LaRoche to pay $18 million in compensatory damages. The women were to receive $9 million each. Hoffmann-LaRoche appealed. The appellate court granted the manufacturer's appeal. It found that the trial court judge “seriously erred" when it allowed some revelations in court while restricting others. FiercePharma reported on this ruling in 2016.

Accutane Class Action

To date, there have been no known class action lawsuits involving Accutane. People filed individual lawsuits against the drug’s manufacturer.

A court in Florida managed the federal Accutane lawsuits. The lawsuits were part of a multidistrict litigation (MDL).

State Accutane lawsuits in New Jersey were managed under a multicounty litigation (MCL).

Courts use MDLs and MCLs to move lawsuits through the legal process with more efficiency.

Please seek the advice of a medical professional before making health care decisions.

Related Pages

Did you find Drugwatch helpful?

8 Cited Research Articles

  1. Silvestrini E. (2007, June 27). Family of Suicidal Pilot Drops Accutane Lawsuit. The Tampa Tribune. Retrieved from
  2. Wichert, B. (2017). NJ Consumers Urge Court To Revive Accutane Litigation. Retrieved from
  3. Sundar, S. (2014, December 12). NJ State Court Tosses Hundreds of Accutane Suits. Retrieved from
  4. Ryan, G. (2013, March 1). Roche Inches Closer to Escaping Accutane MDL. Retrieved from
  5. Sundar, S. (2015, February 23). Roche Thwarts Plaintiffs' Experts in NJ Accutane Litigation. Retrieved from
  6. Caufield, C. (2008, April 23). N.J. Jury Awards $10.5M in Third Accutane Trial. Retrieved from
  7. USA Today. (2002, April 16). Accutane acne drug maker sued over suicide. Retrieved from
  8. Stanton, T. (2016, July 25). Facing thousands of Accutane claims, Roche wins appeal of $18M verdict. Retrieved from
View All Sources
Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(888) 645-1617

To contact Drugwatch Managing Editor Kevin Connolly, call (855) 839-9780.